AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: Kristina Stefanova
Jun. 21--Shares of Celera Genomics Group's parent company shot up 15.4 percent yesterday on reports that the Rockville genomics company and the National Institutes of Health (NIH) will announce a rough draft of the human genomic map next week.
Shares of PE Corp. jumped to $138.50 on the New York Stock Exchange. The company's stock has climbed more than 35 percent in the last three trading days and more than 85 percent since the beginning of the year, when the company said it would compete the genetic map of a person by the end of June.
"We are on track to make our assembly announcement in the month of June," said Heather …